{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T17:26:51Z","timestamp":1696958811906},"reference-count":41,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T00:00:00Z","timestamp":1138060800000},"content-version":"vor","delay-in-days":815,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2003,11]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> The most promising strategies for prevention of type 1 diabetes seem to be in the categories of immunomodulation (e.g., nondepleting anti\u2010CD3, Diapep, linomide) and\/or immunostimulation (e.g., QFA, BCG). We are currently undertaking a research program directed toward better understanding of immunostimulants to help maximize the likelihood of success of future human clinical trials for diabetes prevention. This program is focused on the key areas of optimization of vaccine dose and route of administration, development of surrogate immune markers, and elucidation of the mechanism of protection. The mechanism whereby QFA protects against diabetes currently is not known. The elucidation of the mechanism should help identify the optimal way in which to administer QFA to provide diabetes protection. It may also assist the development of even more potent immunostimulatory vaccines.<\/jats:p>","DOI":"10.1196\/annals.1288.072","type":"journal-article","created":{"date-parts":[[2004,1,12]],"date-time":"2004-01-12T17:32:48Z","timestamp":1073928768000},"page":"423-430","source":"Crossref","is-referenced-by-count":4,"title":["Prevention of Autoimmune Diabetes through Immunostimulation with Q Fever Complement\u2010Fixing Antigen"],"prefix":"10.1111","volume":"1005","author":[{"given":"D. G.","family":"SILVA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"CHARLTON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"COWDEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"PETROVSKY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1994.tb00275.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)91964-6"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6367043"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1996.0096"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.158.6.2947"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/endo.139.1.5641","article-title":"Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25\u2010dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A","volume":"139","author":"Casteels K.M.","year":"1998","journal-title":"Endocrinology"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.4049\/jimmunol.155.2.938","article-title":"Vascular cell adhesion molecule\u2010Ig fusion protein selectively targets activated alpha 4\u2010integrin receptors in vivo: inhibition of autoimmune diabetes in an adoptive transfer model in nonobese diabetic mice","volume":"155","author":"Jakubowski A.","year":"1995","journal-title":"J. Immunol."},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.70.4.510"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.157.8.3737"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.6.980"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.4.1561"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1997.0148"},{"key":"e_1_2_7_14_2","first-page":"217","article-title":"Prevention of autoimmune type 1 diabetes via mucosal tolerance: is mucosal autoantigen administration as safe and effective as it should be? Scand","volume":"52","author":"Hanninen A.","year":"2000","journal-title":"J. Immunol."},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050943"},{"key":"e_1_2_7_16_2","first-page":"306","article-title":"Oral insulin and the induction of tolerance in man: reality or fantasy? Diabetes Metab","volume":"16","author":"Pozzilli P.","year":"2000","journal-title":"Res. Rev."},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.8.1735"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00916571"},{"key":"e_1_2_7_19_2","first-page":"59","article-title":"Autologous mixed lymphocyte reaction in man: VI","volume":"11","author":"Gupta S.","year":"1983","journal-title":"Deficiency of autologous mixed lymphocyte reaction in type I (insulin-dependent) diabetes mellitus. J. Clin. Lab. Immunol."},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(89)90155-4"},{"key":"e_1_2_7_21_2","first-page":"25","article-title":"Depressed suppressor cell activity in patients with newly diagnosed insulin\u2010dependent diabetes mellitus","volume":"41","author":"Buschard K.","year":"1980","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90586-3"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/dmr.5610080104"},{"key":"e_1_2_7_24_2","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.4049\/jimmunol.150.6.2534","article-title":"Defects in the differentiation and function of antigen presenting cells in NOD\/Lt mice","volume":"150","author":"Serreze D.V.","year":"1993","journal-title":"J. Immunol."},{"key":"e_1_2_7_25_2","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.4049\/jimmunol.140.11.3801","article-title":"Defective activation of T suppressor cell function in nonobese diabetic mice: potential relation to cytokine deficiencies","volume":"140","author":"Serreze D.V.","year":"1988","journal-title":"J. Immunol."},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.3.1233"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/5.2.169"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.35.4.496"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.40.6.715"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.39.5.583"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1997.0136"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(90)90017-N"},{"key":"e_1_2_7_33_2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2337\/diab.46.5.758","article-title":"Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta\u2010cell antigens","volume":"46","author":"Elias D.","year":"1997","journal-title":"Diabetes"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06801-5"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91583-0"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.10.1703"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.10.1691"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1139\/m74-101"},{"key":"e_1_2_7_39_2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/iai.11.2.280-286.1975","article-title":"Detection of long\u2010term cellular immunity to Coxiella burnetii as assayed by lymphocyte transformation","volume":"11","author":"Jerrells T.R.","year":"1975","journal-title":"Infect. Immunol."},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1993.tb08226.x"},{"key":"e_1_2_7_41_2","first-page":"319","article-title":"Resistance to Babesia spp","volume":"24","author":"Clark I.A.","year":"1979","journal-title":"and Plasmodium sp. in mice pretreated with an extract of Coxiella burnetii. Infect. Immunol."},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1990.tb42221.x"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1196%2Fannals.1288.072","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1196\/annals.1288.072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:52:15Z","timestamp":1695689535000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1196\/annals.1288.072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["10.1196\/annals.1288.072"],"URL":"https:\/\/doi.org\/10.1196\/annals.1288.072","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}